Levalbuterol: Difference between revisions

From Doc Moates Wiki
Jump to navigation Jump to search
NCLEX nursing pharmacology monographs — batch import
 
Add medication infobox (Drugbox) to monographs
 
Line 1: Line 1:
{{Drugbox
| name = Levalbuterol
| brand = Xopenex
| therapeutic = Bronchodilator
| pharmacologic = Short-acting beta-2 agonist
| onset = Onset minutes; duration 3 to 6 hours.
| halflife = Similar to albuterol; no routine level.
| routes = Inhaled
| highalert = No
| blackbox = None
| antidote = Supportive care.
| pregnancy = Use if needed.
}}
<div style="border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;">
<div style="border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;">
''Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and '''must be verified against current manufacturer labeling before clinical use'''. This is educational content, not prescribing guidance.''
''Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and '''must be verified against current manufacturer labeling before clinical use'''. This is educational content, not prescribing guidance.''

Latest revision as of 16:09, 17 June 2026

Levalbuterol
Drug monograph · NCLEX study reference
Trade namesXopenex
Therapeutic classBronchodilator
Pharmacologic classShort-acting beta-2 agonist
Onset / peak / durationOnset minutes; duration 3 to 6 hours.
Half-life / levelSimilar to albuterol; no routine level.
RoutesInhaled
High-alert (ISMP)No
Black box warningNone
Antidote / reversalSupportive care.
Pregnancy / lactationUse if needed.

Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.

Levalbuterol (brand name Xopenex) — Bronchodilator; Short-acting beta-2 agonist.

Identification

  • Therapeutic class: Bronchodilator.
  • Pharmacologic class: Short-acting beta-2 agonist.

Pharmacology

  • Mechanism of action: Active isomer of albuterol with similar bronchodilation.
  • Onset / peak / duration: Onset minutes; duration 3 to 6 hours.
  • Half-life / therapeutic level: Similar to albuterol; no routine level.

Clinical use

  • Indications: Bronchospasm, asthma, COPD.
  • Usual dose, route, frequency: Inhaler or nebulized every 6 to 8 hours.
  • Maximum dose / adjustments: Frequent use signals poor control.

Safety

  • Contraindications: Hypersensitivity; cardiac caution.
  • Black box warning: None.
  • Interactions: Same as albuterol.
  • Pregnancy / lactation: Use if needed.
  • High-alert: No.

Adverse effects

  • Common side effects: Tremor, tachycardia, nervousness.
  • Serious effects to report: Paradoxical bronchospasm, chest pain.
  • Antidote / reversal: Supportive care.

Nursing process

  • Assessment before administration: Lung sounds, heart rate, respiratory status.
  • Interventions during therapy: Assess relief; bronchodilator before steroid.
  • Monitor: Respiratory status, heart rate.
  • Evaluation / expected outcome: Improved breathing.

Patient teaching

  • Patient teaching: Rescue use; report increasing need.
  • Notify provider if: No relief, chest pain, more frequent use.
  • Administration tips: Same technique as albuterol.